Clinical Trials Browser

Neurilemmoma × Bevacizumab × Clear all

NCT01083966 2026-06-01

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Phase 1 Suspended

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic